Tumor mutational burden as a predictive biomarker for non-small cell lung cancer treated with immune checkpoint inhibitors of PD-1/PD-L1
Minmin Shao, Yue‐Ping Xu, Jinjing Zhang, Mao Mao, Meng‐Chuan Wang
Topics & Concepts
MedicineInternal medicineOncologyLung cancerBiomarkerCohortImmune checkpointPD-L1ImmunotherapyRetrospective cohort studyCancerBiochemistryChemistryCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging